| William G Binegar, MD | |
|
301 W Myrtle St, Boise, ID 83702-7656 | |
| (208) 342-8200 | |
| (208) 342-8202 |
| Full Name | William G Binegar |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 37 Years |
| Location | 301 W Myrtle St, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457393811 | NPI | - | NPPES |
| 003602300 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | M5826 (Idaho) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | M5826 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| William G Binegar Md Pa | 9436147840 | 4 |
News Archive
Coronavirus infections are rising so fast in Fresno County that California public health officials have identified it as one of nearly a dozen counties entering dangerous territory as economies reopen.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
"Poverty is the leading cause of many vitamin deficiencies, especially vitamin A," and the problem is acute in sub-Saharan Africa and South Asia, where food staples such as cassava and rice are high in calories but low in nutrients, Inter Press Service reports.
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
› Verified 5 days ago
| Entity Name | William G Binegar Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124060447 PECOS PAC ID: 9436147840 Enrollment ID: O20040504001346 |
News Archive
Coronavirus infections are rising so fast in Fresno County that California public health officials have identified it as one of nearly a dozen counties entering dangerous territory as economies reopen.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
"Poverty is the leading cause of many vitamin deficiencies, especially vitamin A," and the problem is acute in sub-Saharan Africa and South Asia, where food staples such as cassava and rice are high in calories but low in nutrients, Inter Press Service reports.
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William G Binegar, MD 301 W Myrtle St, Boise, ID 83702-7656 Ph: (208) 342-8200 | William G Binegar, MD 301 W Myrtle St, Boise, ID 83702-7656 Ph: (208) 342-8200 |
News Archive
Coronavirus infections are rising so fast in Fresno County that California public health officials have identified it as one of nearly a dozen counties entering dangerous territory as economies reopen.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
"Poverty is the leading cause of many vitamin deficiencies, especially vitamin A," and the problem is acute in sub-Saharan Africa and South Asia, where food staples such as cassava and rice are high in calories but low in nutrients, Inter Press Service reports.
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
› Verified 5 days ago
Allison Elisabeth May, Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2222 | |
John Mather Hine, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 8800 W Emerald St, Boise, ID 83704 Phone: 208-373-5000 | |
Steven J Love, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 W State St, Boise, ID 83702 Phone: 208-336-0895 | |
Dr. Tomasz Adam Murawski, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-5170 Fax: 208-367-5180 | |
Dr. Timothy A Bialobrzeski, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 338 E Bannock St, Boise, ID 83712 Phone: 208-336-0895 | |
Brent Kenner Childers, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 8800 W Emerald St, Boise, ID 83704 Phone: 208-373-5000 | |
Kirk A. Miller, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 600 Robbins Rd, Suite 401, Boise, ID 83702 Phone: 208-489-4279 Fax: 208-424-8555 |